The extracellular signal-regulated kinase (ERK) signal transduction pathway, which regulates cell proliferation, differentiation, and survival in response to extracellular stimuli, is constitutively activated in most malignant melanomas due to oncogenic mutations of NRAS or BRAF genes (1). The gene discussed is BRAF; the disease is melanoma.